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Abstract Endoscopic techniques can be considered reasonably safe since they are widely used
and the rate of complications is extremely low. Still complications do occur and in order to
avoid them, the evaluation of the patient before and after any intervention is of the utmost
importance. In this article, issues concerning the preparation of the patient and informed con-
sent, the general assessment -- medical history, current medications, physical examination,
laboratory tests, radiological evaluation and analysis of the indication and planning will be
addressed. The post intervention evaluation will also be discussed, in order to detect and treat
complications and decide on the ﬁnal guidance for the patient after discharge.
There are very few up-to-date studies or publications dealing with these areas, the evidence
level remains low and most recommendations are based on common sense and expert opinion.
© 2011 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L. All rights
reserved.
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Avaliac¸ão do paciente submetido a procedimentos endoscópicos
Resumo As técnicas endoscópicas podem ser consideradas razoavelmente seguras dado que
são amplamente utilizadas e o índice de complicac¸ões é extremamente reduzido. Ainda assim,
ocorrem complicac¸ões e, para as evitar, a avaliac¸ão do paciente antes e depois de qualquer
intervenc¸ão, é da maior importância. Neste artigo, serão abordadas as questões relacionadas
com a preparac¸ão do paciente e o consentimento esclarecido, a avaliac¸ão geral -- historial
médico, medicac¸ão actual, exame físico, testes de laboratório, avaliac¸ão radiológica e análise
da indicac¸ão e planeamento. A avaliac¸ão após a intervenc¸ão também será discutida, para
detectar e tratar complicac¸ões e determinar a orientac¸ão ﬁnal para o paciente, após a alta.Existem muito poucos estudos ou publicac¸ões actualizados que abordem estas áreas, o nível
de evidência permanece baixo e
opinião de peritos.
© 2011 Sociedade Portuguesa d
direitos reservados.
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873-2159/$ – see front matter © 2011 Sociedade Portuguesa de Pneumolo
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Introduction
Endoscopic techniques, ﬂexible, rigid bronchoscopy and tho-
racoscopy are central tools in the evaluation and treatment
of respiratory disorders and their use has been steadily
growing.The ﬁrst rigid bronchoscopy was performed in 1897
when Gustav Killian removed a piece of pork bone from
the bronchus of a 63-year-old farmer, thus avoiding a
tracheotomy.1,2 IKEDA3 in the late 60s pioneered ﬁberoptic
bronchoscopy as a tool to enter subsegmental bronchi and
obtain specimens for early diagnosis of lung cancer. Dur-
ing the last 30 years the ﬂexible bronchoscope has become
the diagnostic instrument of choice for visualization of the
bronchial tree as it is less invasive, does not require gen-
eral anaesthesia and provides much better visualization of
the smaller peripheral airways. The introduction of laser
technology into the tracheobronchial tree and the advent
of airway stents in the early 1990s caused a resurgence of
rigid bronchoscopy in the management of both benign and
malignant central airway obstruction.4--6
Thoracoscopy began in 1908 with Jacobeus,7 and was
extensively used in the treatment of tuberculosis, for pneu-
mothorax induction and lyses of adhesions. When effective
treatment for TB was discovered, interest in this technique
disappeared. With technical improvements during the 90s,
thoracoscopy regained popularity for dealing with undiag-
nosed pleural effusion.
These techniques can be considered safe since they are
widely used and the rate of complications is extremely
low.8--10 A recent retrospective analysis of 23.682 patients
undergoing bronchoscopy over a period of 11 years showed a
mortality rate of 0.013% with a complication rate of 0.739%.9
Mortality from medical thoracoscopy ranges between 0.09
and 0.24%.11 Despite these small numbers, complications
do occur and in order to avoid them, the evaluation of
the patient before and after any intervention, is of utmost
importance. Considering that this issue is of major concern,
it is surprising that there are very few up to date studies
dealing with these areas, the evidence level remains low
and most recommendations (European Respiratory Society,
American Thoracic Society and national societies) are based
on common sense and the very small number of evidence
based publications.
Figure 1 Operating room and monitoring of vital signs.
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The aim of this article is to address pre- and post evalu-
tion workup of patients undergoing endoscopic techniques
n order to determine the ﬁtness of the patient and the
deal planning and strategy in order to obtain the maximum
eneﬁt with the lowest risk.
The issues discussed are the preparation of the patient
nd informed consent, the general assessment -- medical his-
ory, current medications, physical examination, laboratory
ests, radiological evaluation and analysis of the indication
nd planning. The post intervention evaluation will also
e discussed, in order to detect and treat complications
nd decide on the guidance to be given to the patient after
ischarge.
re-operative assessment
reparation and informed consent
he importance of relevant and comprehensible patient
nformation before diagnostic and therapeutic procedures
s increasingly recognized, and improves the patient’s tol-
rance of the procedure.12--14 There are several ways of
elping patients, for example, careful explanation and
elaxing music, have been found to calm patients and reduce
nxiety.15,16 Patients and their relatives may have questions
bout the procedure and later management and sufﬁcient
ime should be made available for this. The clinician should
e able to explain the procedure, its purpose, the associated
isks and possible adverse outcomes and the patient should
e able to give consent entirely voluntarily.
It is the responsibility of the doctor who performs the
xamination to ensure that a valid consent form has been
igned. An intervention performed without consent may lead
o legal proceedings.17
eneral assessment -- history and physical
xamination
t is essential to have detailed information about the
atient’s current and past medical history for formulating
iagnostic hypothesis and planning the examination. Rele-
ant information should be obtained about smoking history,
ccupational exposure, and comorbidities such as asthma,
OPD, cardiovascular status (myocardial infarction, arrhyth-
ias, unstable angina, congestive heart failure), bleeding
isorders (thrombocytopenia, immunossupression, uremia,
mpared liver function), allergies and medications (antia-
regating agents, anticoagulant therapy).
Before any procedure, it is useful to know the basal phys-
cal characteristics of the patient. Monitoring of vital signs
heart rate, respiratory rate, blood pressure and O2 satura-
ion) is mandatory (Fig. 1). Visual assessment of the patient
s required to detect signs of respiratory distress, superior
ena cava syndrome, stridor, hoarseness, anatomic abnor-
alities of the face and neck (for example wounds, burns
nd fractures), and spine deformities that could preclude
he performance of the examination. Lung auscultation to
ule out asymmetries of breath sounds (atelectasis, pneu-
othorax), abnormal breath sounds (wheezing, crackles)
nables the physician to understand whether they had
xisted previously or are a consequence of the procedure.
5 A. Magalhães
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Table 1 Pre-procedure evaluation.
Patient information
Informed consent
Fasting
Venous access
History and physical examination
Laboratory tests
Total blood count
Platelet counta
BUNb
Liver function testb
Ionogramb
Coagulation studyb
ABGb
ECG, ecocardiogram, spirometryb
Imaging
Chest X-ray
Chest CT
Planning and strategy
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erformance status evaluation is also needed to prevent the
nnecessary performance of invasive techniques in termi-
ally ill patients who may be best treated with comfort
easures.
aboratory tests and imaging
otal blood count and platelet count, to eliminate anaemia
nd thrombocytopenia, blood chemistry to detect elec-
rolytic imbalances, impaired renal and liver function that
ay impact on blood clotting and drug metabolism (namely
naesthetics and sedatives often used during procedures)
re considered routine workup. In speciﬁc situations, like
lderly patients, or patients with a past history of heart dis-
ase, electrocardiogram (EEG) and echocardiogram might
lso be necessary. In patients with COPD and respiratory
nsufﬁciency, arterial blood gas (ABG) analyses and lung
unction tests might be helpful.
Imaging studies such as chest X-ray, chest CT and chest
ltrasound should be carefully analyzed prior to any inter-
ention, since they can provide valuable information for the
lanning of the technique.
valuation of the indication and planning
t is mandatory that for every invasive technique the clin-
cian be aware of the indications, contraindications and
ossible complications. After following the steps addressed
bove regarding patient ﬁtness for the procedure, it is cru-
ial to go through the indication, bearing in mind that
iagnostic procedures of any kind should only be performed
n patients for whom a diagnosis is going to alter manage-
ent and where the beneﬁt outweighs the risks.
In addition, careful planning helps in the choice of
he right diagnostic techniques -- biopsy, brushings, trans-
ronchial needle aspiration biopsy (TBNA), bronchoalveolar
avage (BAL) and transbronchial lung biopsy (TBLB) -- in order
o get the most out of the procedure.
In relation to therapeutic techniques, it is important to
onsider patient performance status and life expectancy and
nly perform therapies that will impact on quality of life.
lso the choice of the right therapy -- laser, mechanical
ebulking, eletrocautery, criotherapy, photodynamic ther-
py, stents -- is crucial to ensure a successful outcome
Table 1).
pecial considerations on bronchoscopy
lthough bronchoscopy is a safe technique with low rates of
orbidity and mortality,8,9 care should be taken in certain
ituations.
espiratory
atients with severe COPD (FEV1 < 40% or less than 1 L)
hould have an ABG measurement before bronchoscopy,
edation should be avoided and supplementary O2 should be
iven with caution.18 In the presence of a highly hypoxemic
atient, bronchoscopy can be performed with noninva-
ive pressure ventilation via a face mask, which solves
t
c
t
ta Not routinely requested before FOB except in case of TBLB.
b Not routinely requested unless comorbidities.
his speciﬁc problem.19 If it is not possible to ensure ade-
uate oxygenation, bronchoscopy should not take place.
rterial oxygen tension (PaO2) >60mmHg at rest or a sat-
ration >90%, with O2 supplements would be considered
cceptable safety thresholds.20--22
Asthmatic patients are more prone to develop bron-
hospasm and so a bronchodilator should be given prior to
ronchoscopy.8
ardiovascular
f there is a history of recent myocardial infarction, ﬁbreop-
ic bronchoscopy must be postponed for at least 6 weeks,8
f possible. Unstable angina and poorly controlled conges-
ive heart failure should also lead to postponement of an
lective procedure.
nticoagulation and antiplatelet agents
n order to prevent bleeding complications, anticoagulant
herapy should be suspended 3 days earlier or be reverted
ith vitamin K.8 If it is absolutely necessary to main-
ain hipocoagulation, heparin should be started and the
NR <1.5. Regarding antiplatelet agents, a study23 concluded
hat clopidogrel increases risk of bleeding and should be
nterrupted 5 days before bronchoscopy with transbronchial
iopsies. Aspirin, on the other hand, is considered to be
afe.24 If transbronchial lung biopsies (TBLB) are to be per-
ormed it is essential to check platelet count, protrombine
ime and tromboplastin time. There is no evidence in rela-
ion to ‘‘safe’’ levels of coagulation parameters or platelet
ounts, but a platelet count of 50,000mL−1 and a pro-
hrombin and partial thromboplastin time within 1--2 s of
he control value is generally regarded as safe.25
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Age
Elderly patients are prone to comorbidity and a decreased
metabolism of some drugs, namely topic anaesthetics and
midazolam. However, several studies have shown that they
tolerate the procedure well and age per se is not a
contraindication.26,27
Bronchoscopy in the ICU
Patients in the ICU are high risk patients and beneﬁts must
outweigh the risks. Pre-oxygenation must be ensured by
increasing the inspired fraction of O2 (FIO2) to 100% and the
exam should be performed with a swivel connector with a
perforated diaphragm, through which the bronchoscope is
inserted, allowing simultaneous ventilation.28 Endotracheal
tube size and external diameter of the bronchoscope have
to be checked prior to the exam to avoid damage to the
scope of vision and impaired ventilation.
Head trauma patients should be monitored for intracra-
nial pressure and have complete anaesthesia with neuro-
muscular blockage during bronchoscopy.8
Prophylaxis of endocarditis
Antibiotic prophylaxis before bronchoscopy is not recom-
mended, unless the procedure involves incision of the
respiratory mucosa.29
Pre medication
Atropine to dry the airways is no longer recommended
because several studies have shown that there is no ben-
eﬁt compared to placebo and it has side effects like
tachycardia.30 Although the routine use of sedation is not a
prerequisite before bronchoscopy it should be offered when-
ever there is no contraindication31,32
Fasting
Patients undergoing bronchoscopy should have no food by
mouth for 4 h before procedure or clear ﬂuids by mouth 2 h
before,33 patients should be allowed to take their regular
medication, except for any that have to be suspended.
An intravenous access should always be provided.
Rigid bronchoscopy (RB)
Rigid bronchoscopy is performed under general anaesthe-
sia and so the ﬁrst thing to do is to evaluate the state of
health of the patient. Ventilatory function, cardiac status,
hematologic, renal and liver function all must be assessed.
Anatomical features must be taken into consideration.
Patients who cannot tolerate hyperextension of the neck or
rotation of the neck due to a fused or unstable cervical spine
should not be considered for bronchoscopy. Patients with
unstable midline facial fractures or deformities of the mouth
are not suitable to undergo rigid bronchoscopy.
Rigid bronchoscopy is the preferred option for other
endobronchial therapies4,34,35 such as laser, eletrocautery,
P
A
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riotherapy and stent placement. As well as under-
tanding the indications, contraindications and possible
omplications of RB,10 it is also essential to know about these
echniques so as to be able to select the most appropriate
or each particular case. Patients undergoing these thera-
ies generally have poor performance status and relevant
omorbidities, so it is crucial to analyze the risk/beneﬁt. For
patient undergoing laser therapy it is important to know
hether the symptoms are caused by the obstruction, if the
ung has been collapsed for more than 4--6 weeks, if there is
nvolvement of the pulmonary artery, if there is functional
ung distal to the obstruction.
If a stent is to be placed, the following must be taken into
ccount: type of obstruction (intrinsic/extrinsic), localiza-
ion (central airways), and patency distal to the obstruction.
n order to answer these questions, there should be a careful
adiological and endoscopic evaluation prior to any interven-
ion.
horacoscopy
edical thoracoscopy is generally performed under local
naesthesia and conscious sedation and is considered a
afe procedure.11 Besides knowing the indications, con-
raindications and complications, a detailed medical history,
rug history, physical examination and imaging, chest X-ray
nd chest CT, are crucial to any preoperative evaluation.
lthough an ultrasound prior to the procedure is not manda-
ory, it increases safety and should be used whenever
ossible.36
Patient general health status is assessed by a total blood
ount, blood chemistry and coagulation study. Depending
n age (>65 years) and the presence of certain comorbor-
idities, ECG, ABG analyses and spirometry (severe COPD
atients) may be added to the screening.
Dyspnea in a patient with a pleural effusion is not a con-
ern since it will improve with effusion drainage, during
horacoscopy.
The procedure involves intravenous sedation/analgesia
nd so a reasonable level of oxygenation should be assured
>90% with supplemental oxygen during the procedure).36
isual inspection of the point of entry is important in decid-
ng where to insert the thoracoscope, avoiding skin infection
r other abnormalities like sequelae of previous radiother-
py.
Patients must be able to tolerate lateral decubitus during
he whole of the procedure.
Like other invasive techniques performed through surgi-
ally scrubbed skin, thoracoscopy is not likely to produce
igniﬁcant bacteriemia and so proﬁlactic antibiotics are not
ecommended.29 When there is pleural space infection it is
dvisable to give proﬁlactic antibiotics in patients at risk of
ndocarditis.29
If pleurodesis is a possibility, it is important to analyze the
atient performance status, namely life expectancy (supe-
ior to 3 months) and to rule out a trapped lung.ost intervention evaluation
ll patients should be observed for at least 30--60min after
ronchoscopy or for 2 h after rigid bronchoscopy or inter-
52
Table 2 Post procedure evaluation.
Surveillance 30--60min (respiratory distress signs,
consciousness)a
Vital signs monitoring (heart rate, respiratory rate, blood
pressure, pulse oximetry)
O2 supplementation
Chest X-rayb
ABG, ECGc
Verbal and written information
a 2 h if general anaesthesia.
b 1 h later if TBLB.
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British Thoracic Society guidelines on diagnostic ﬂexible bron-c If cardiac or respiratory complications.
ention. Observation can take place in the operating room
r in a recovery room.
The monitoring of ventilation features, such as SaO2,
he respiratory rate and pattern (visible signs of bronchial
bstruction and respiratory distress), ABG when required
nd hemodynamic features, such as blood pressure, heart
ate and ECG, is of paramount importance.
Post-operative care should focus on the most common
omplications, such as acute airway obstruction, bleed-
ng, mucus retention, pneumothorax, respiratory failure and
ardiac dysfunction. Hypoxic events subsequent to bron-
hoscopic procedures can occur in as many as 80% of the
atients; oxygen supplementation after the procedure suc-
essfully reduces such hypoxic episodes, particularly in
ubjects with impaired lung function.37
Discharge from the recovery room can be performed
hen the patient is conscious, when all aspects of the venti-
atory and airway reﬂexes have been restored, and when the
atient is able to take deep breaths and to cough effectively
ithout signs of obstruction.
Where patients have been sedated they must be advised
fter discharge not to drive or operate machinery or sign
egal documents in the following 24 h.8
Patients should be discharged in the presence of a
elative capable of reporting complications and written
nformation about the procedure and its complications
hould be provided (Table 2).
ost bronchoscopy
f the patient was submitted to transbronchial biopsy, a chest
-ray should be performed 1 h later to rule out pneumoth-
rax. Verbal and written information about the procedure
hould be provided with instructions to go to the emergency
epartment in case of dyspnea or chest pain. Fever after
AL is a possible complication and patients should also be
arned about this.
If a stent has been placed, the patient should be given
card identifying the type, the size and location of the
tent and a contact phone number. A follow up visit should
e scheduled; this is generally between 4 and 6 weeks but
his may vary between centres. A study addressing this
ssue concluded that routine follow up bronchoscopies were
ot justiﬁed.38 Nebulizations and mucolitycs may be recom-
ended but there are no controlled studies.A. Magalhães
ost thoracoscopy
s medical thoracoscopy is performed with conscious seda-
ion, monitoring of vital signs is essential until patient is
ully recovered and is no longer at risk of cardiac and
espiratory depression. Chest tube functioning should be
hecked for bleeding and air leaks. A chest X-ray should
e performed to monitor lung reexpansion. Proper analge-
ia should be supplied especially if a talc pleurodesis has
een performed. Two hours later, the chest tube should be
onnected to active suctioning to promote lung reexpan-
ion. Removal of the chest tube should be considered when
roduction of pleural ﬂuid is less than 100--200ml/day and
he lung is fully expanded.11 In mesothelioma it is common
ractice to perform radiotherapy within 2 weeks at the tro-
ar site of entry to avoid seeding, but there are studies that
o not agree with this.39
onclusion
thorough evaluation performed prior to any intervention,
ncluding medical history, drug history, physical examina-
ion, blood tests and imaging, is critical to avoid unnecessary
isks and to achieve a successful outcome. Diagnostic pro-
edures must always impact on patient management and
herapeutic interventions must take into account patient
erformance status and life expectancy. Post operatively
t is important to be aware of the possible complications
nd provide adequate surveillance and monitoring to guar-
ntee patient safety and make appropriate decisions for
he future. It does not matter how many technological
nnovations and skills there are in the ﬁeld of endoscopic
echniques, this process of decision making before and after
ny intervention will remain the key point.
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